Regarding mortality, a total of 16 deaths were reported in semaglutide treatment groups, 8 deaths were reported in active comparator groups (empagliflozin, sitagliptin, liraglutide, and dulaglutide), and 3 deaths were reported in placebo groups
BPI Labs received an FDA Warning Letter in March 2025 over its epinephrine nasal solution, for which the FDA recommended a recall, and it was previously referred to the Florida Board of Pharmacy back in 2021
Signs of cobalamin deficiency in dogs A dog with cobalamin deficiency may have one or more of the following symptoms: Lethargy Loss of appetite Change in eating habits Dull coat Loss of muscle mass Weight loss Weakness Diarrhea Loss of interest in playing Failure to thrive Mental dullness Seizures Cobalamin deficiency in dogs primarily occurs when there is a problem with cobalamin absorption
ACD is often included in the differential diagnosis for AD as they can be similar in their clinical presentations, and AD was considered an important risk factor for the occurrence of urticaria 25